Regeneron Pharmaceuticals (REGN) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.04% |
| Dec 31, 2025 | 2.51% |
| Sep 30, 2025 | 0.90% |
| Jun 30, 2025 | 3.62% |
| Mar 31, 2025 | -3.70% |
| Dec 31, 2024 | 10.33% |
| Sep 30, 2024 | 10.65% |
| Jun 30, 2024 | 12.32% |
| Mar 31, 2024 | -0.54% |
| Dec 31, 2023 | 3,334.30% |
| Sep 30, 2023 | 14.53% |
| Jun 30, 2023 | 10.53% |
| Mar 31, 2023 | 6,224.20% |
| Dec 31, 2022 | -97.98% |
| Sep 30, 2022 | -14.96% |
| Jun 30, 2022 | -44.40% |
| Mar 31, 2022 | -98.02% |
| Dec 31, 2021 | 104.37% |
| Sep 30, 2021 | 50.51% |
| Jun 30, 2021 | 163.24% |
| Mar 31, 2021 | 38.32% |
| Dec 31, 2020 | 30.02% |
| Sep 30, 2020 | 31.56% |
| Jun 30, 2020 | 23.72% |
| Mar 31, 2020 | 33.19% |
| Dec 31, 2019 | -3.34% |
| Sep 30, 2019 | 4.82% |
| Jun 30, 2019 | -1.88% |
| Mar 31, 2019 | -9.19% |
| Dec 31, 2018 | 21.83% |
| Sep 30, 2018 | 10.85% |
| Jun 30, 2018 | 9.38% |
| Mar 31, 2018 | 14.59% |
| Dec 31, 2017 | 28.98% |
| Sep 30, 2017 | 23.00% |
| Jun 30, 2017 | 21.23% |
| Mar 31, 2017 | 9.84% |
| Dec 31, 2016 | 11.73% |
| Sep 30, 2016 | 7.27% |
| Jun 30, 2016 | 21.43% |
| Mar 31, 2016 | 38.09% |
| Dec 31, 2015 | 36.86% |
| Sep 30, 2015 | 56.72% |
| Jun 30, 2015 | 50.01% |
| Mar 31, 2015 | 38.97% |
| Dec 31, 2014 | 31.44% |
| Sep 30, 2014 | 21.57% |
| Jun 30, 2014 | 45.46% |
| Mar 31, 2014 | 42.32% |
| Dec 31, 2013 | 47.23% |
| Sep 30, 2013 | 39.59% |
| Jun 30, 2013 | 50.34% |
| Mar 31, 2013 | 89.68% |
| Dec 31, 2012 | 237.14% |
| Sep 30, 2012 | 315.90% |
| Jun 30, 2012 | 182.35% |
| Mar 31, 2012 | 106.58% |
| Dec 31, 2011 | 1,043.08% |
| Sep 30, 2011 | 1,983.33% |
| Jun 30, 2011 | -6.97% |
| Mar 31, 2011 | 5,849.31% |
| Dec 31, 2010 | -199.28% |
| Sep 30, 2010 | -95.80% |
| Jun 30, 2010 | 2,475.24% |